Author:
O'Malley David M.,Richardson Debra L.,Rheaume Patrick S.,Salani Ritu,Eisenhauer Eric L.,McCann Georgia A.,Fowler Jeffrey M.,Copeland Larry J.,Cohn David E.,Backes Floor J.
Subject
Obstetrics and Gynecology,Oncology
Reference20 articles.
1. The microtubule-affecting drug paclitaxel has antiangiogenic activity;Belotti;Clin Cancer Res,1996
2. Paclitaxel (Taxol): an inhibitor of angiogenesis in a highly vascularized transgenic breast cancer;Lau;Cancer Biother Radiopharm,1999
3. Weekly paclitaxel in the treatment of recurrent ovarian carcinoma;Byrd;Eur J Gynaecol Oncol,2007
4. Prospective evaluations of continuous weekly paclitaxel regimen in recurrent platinum-resistant epithelial ovarian cancer;Le;Gynecol Oncol,2006
5. A phase II study of weekly paclitaxel in platinum and paclitaxel-resistant ovarian cancer patients;Kaern;Eur J Gynaecol Oncol,2002